2. Election goes to the House, where President Trump is reelected, and Senate where Mike Pence is reelected.
NOTES:
A.Dersh says that SCOTUS will likely rule in Trump's favor against individual states PROVIDED his legal team can show that in such state there are enough "Illegal" ballots to bring that state's totals into question. (Rudy say's they already have this evidence.)
B. Dersh also stated that this (favorable) analysis DOES NOT EVEN TAKE INTO ACCOUNT the situation if Sidney Powell can prove fraud in the computers.
What I am anxious about is all the downticket votes that got stolen. That was brought up in Rudy and Sidney’s presser a couple days ago. Hwo to fix that without voting again? Stolen not just with the software etc but illegals voting, dead, etcetc. No paper trail for many states, and even supposedly a trail the states run by Dems cannot be trusted at all. Like mine...
https://freerepublic.com/focus/news/3908411/posts?page=1
BREAKING: FDA Approves Emergency Use Authorization for Regeneron Antibody Treatment for Covid-19
Townhall ^ | 11/21/2020 | Beth Baumann
Posted on 11/21/2020, 10:27:51 PM by SeekAndFind
The Federal Drug Administration Saturday night approved an Emergency Use Authorization for an antibody treatment President Donald Trump received shortly after being diagnosed with the Wuhan coronavirus. The manufacturer, Regeneron, received the green light for their cocktail of two antibodies – or casirivimab and imdevimab – that appear to be effective for those with mild to moderate coronavirus.
The two antibodies, referred to as monoclonal antibodies, are created in a lab and mimic the human body’s natural immune system. When administered the cocktail prevents the virus from attaching to human cells.
In order to receive the treatment, a patient must be 12 years or older, weigh at least 88 pounds and are at high-risk for progressing to a severe stage of the virus. A patient cannot be hospitalized or require oxygen because of the Wuhan coronavirus.
According to the FDA, taking the antibody cocktail has shown to reduce the number of hospitalizations and emergency room visits in those who are high risk for the disease.
Regeneron will have enough doses of the cocktail for 80,000 patients by the end of November. That number will increase to 200,000 patients by the first week of January and 300,000 by the end of January, the New York Times reported.
more...